Neoadjuvant Docetaxel in Breast Cancer: 3-Year Survival Results from the Aberdeen Trial

Clinical Breast Cancer - Tập 3 - Trang S69-S74 - 2002
Steven D. Heys1, Andrew W. Hutcheon1, T. K. Sarkar1, Keith N. Ogston1, Iain D. Miller1, Simon Payne1, Ian C. P. Smith1, Leslie G. Walker2, Oleg Eremin3
1Departments of Surgery, Pathology, Medical and Clinical Oncology, University of Aberdeen, Scotland, UK
2University of Hull, England
3Lincoln County Hospital, Lincoln, England

Tóm tắt

Từ khóa


Tài liệu tham khảo

De Lena, 1978, Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer, Cancer Chemother Pharmacol, 1, 53, 10.1007/BF00253147

Jacquillat, 1990, Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer, Cancer, 66, 119, 10.1002/1097-0142(19900701)66:1<119::AID-CNCR2820660122>3.0.CO;2-3

Hortobagyi, 1988, Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy, Cancer, 62, 2507, 10.1002/1097-0142(19881215)62:12<2507::AID-CNCR2820621210>3.0.CO;2-D

Heys, 1993, Multimodality treatment in the management of locally advanced breast cancer, JR Coll Surg Edinb, 38, 9

Heys, 1994, Role of multimodality therapy in the management of locally advanced carcinoma of the breast, J Am Coll Surg, 179, 493

Bonadonna, 1990, Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimetres or more, J Natl Cancer Inst, 82, 1539, 10.1093/jnci/82.19.1539

Bonnadonna, 1996, Primary chemotherapy in surgically resectable breast cancer, CA Cancer J Clin, 45, 227, 10.3322/canjclin.45.4.227

1998, Polychemotherapy for early breast cancer: an overview of the randomised trials, Lancet, 352, 930, 10.1016/S0140-6736(98)03301-7

van der Hage, 2001, Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902, J Clin Oncol, 19, 4224, 10.1200/JCO.2001.19.22.4224

Mauriac, 1999, Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS), Ann Oncol, 10, 47, 10.1023/A:1008337009350

Scholl, 1994, Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumors considered too large for breast conserving surgery: preliminary results of a randomised trial: S6, Eur J Cancer, 30A, 645, 10.1016/0959-8049(94)90537-1

Semiglazov, 1994, Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer, Ann Oncol, 5, 591, 10.1093/oxfordjournals.annonc.a058929

Powles, 1995, Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer, J Clin Oncol, 13, 547, 10.1200/JCO.1995.13.3.547

Wolmark, 2001, Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18, J Natl Cancer Inst Monogr, 30, 96, 10.1093/oxfordjournals.jncimonographs.a003469

Makris, 1998, A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer, Ann Oncol, 9, 1179, 10.1023/A:1008400706949

Nabholtz, 2000, Chemotherapy of breast cancer: are the taxanes going to change the natural history of breast cancer?, Expert Opin Pharmacother, 1, 187, 10.1517/14656566.1.2.187

Doliny, 1999, Phase II trial of neoadjuvant (NEO) docetaxel and cisplatin (DP) for the treatment of locally advanced breast cancer (LABC), Proc Am Soc Clin Oncol, 18, 84a

Dorr, 1999, A pilot multimodality study with preoperative and post-operative chemotherapy with taxotere (docetaxel) and adriamycin (doxorubicin) (TA) for locally advanced breast cancer, Proc Am Soc Clin Oncol, 18, 92a

Laurence, 1999, Phase II study of sequential docetaxel (Taxotere, TXT) and doxorubicin (DOX) as primary chemotherapy (CT) for large operable breast cancer (BC), Proc Am Soc Clin Oncol, 8, 98a

Smith, 2002, Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel, J Clin Oncol, 20, 1456, 10.1200/JCO.20.6.1456

Miller, 1981, Reporting results of cancer treatment, Cancer, 47, 207, 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6

Smith, 2001, Issues involved in research into the neoadjuvant treatment of breast cancer, Anticancer Drugs, 12, S25

Chetty, 2000, Management of the axilla in operable breast cancer treated by breast conservation: a randomised clinical trial, Br J Surg, 87, 163, 10.1046/j.1365-2168.2000.01345.x

Eltahir, 1998, Treatment of large and locally advanced breast cancers using neoadjuvant chemotherapy, Am J Surg, 75, 127, 10.1016/S0002-9610(97)00279-1